News
Chronic respiratory illnesses affect millions. Learn how PCPs can effectively manage asthma, COPD, and allergies through ...
Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in ...
People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...
12h
Stockhead on MSNDr Boreham’s Crucible: Sizing up the opportunity for ASX biotech AdheriumPlenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...
Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.
Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results